Experts say the roughly one in five Canadians who experience respiratory allergies aren't imagining things. Seasonal ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

New biologic and targeted therapies are changing the landscape of prurigo nodularis care, offering sustained relief and ...

Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...

Novartis’ anti-IgE antibody Xolair (omalizumab) has been a mainstay of treatment for refractory CSU for many years. However, the drug is heading for patent expiry in Europe this year and in the ...

The new-generation drug – also known as QGE031 – binds more tightly to IgE than Roche-partnered Xolair (omalizumab), and that suggests it could be more effective as a treatment for CSU ...

However, re-exacerbation of symptoms occurred during the tapering of the prednisone daily dose. Therefore, we decided to treat the patient with Omalizumab at the dosage of 300 mg every 4 weeks. (A) ...

Following failed attempts to control her symptoms with second-generation antihistamines, she was started on monthly subcutaneous injections of the monoclonal antibody, omalizumab. The patient ...

President Trump touted a new Executive Order that would more closely align drug prices in the US with those sold in Europe ...

President Donald Trump touted a new executive order that would more closely align drug prices in the US with those sold in Europe and the UK, opening the door for drugs used by millions of ...